Cashing In on Cannabis: 3 Stocks Primed to Surge on Federal Reforms
Multiple cannabis stocks to buy should climb higher thanks to Washington’s efforts to help the sector. So far, the federal government looks poised to undertake two initiatives that should greatly …
Opinion: Here’s why marijuana should not be reclassified as a lower-risk drug
Former DEA agent Michael Brown writes that reclassifying marijuana would embolden Mexican cartels and Chinese legal growing operations while creating greater strains on law enforcement and increasing …
Opinion: Drug cartels would love a lower-risk classification for marijuana
Based on historical actions of the cartels, it can be anticipated that they will establish front companies and invest in legal marijuana farming in states where it is legal to grow and sell marijuana, …
Hawai’i Police Undertake Program To Detect Cannabis Impaired Driving With Help Of Medical Marijuana Patients
The Hawai’i Police Department (HPD) recently participated in a Cannabis Impaired Driving “Green Lab,” the first of its kind in the state. Medical marijuana patients volunteered for this three-day …
Medical Marijuana, Inc. Portfolio Investment Company Neuropathix Announces Grant Award for Parkinson’s Research
SAN DIEGO, CA – () – June 26, 2024 – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), announced today that Kannalife Sciences, Inc. (Kannalife”), a wholly-owned subsidiary of the Company’s …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Pot stocks fall as US DEA pushes cannabis reclassification hearing to December
The HHS’ National Survey on Drug Use and Health for 2023 showed that marijuana is the most commonly used illicit drug, opens new tab, with 21.8% of people aged 12 or older, or 61.8 million people, …
3 Weed Stocks Sinking on Reclassification Hearing Update
The U.S. Drug Enforcement Administration (DEA) today announced a proposal hearing on the reclassification of marijuana as a less restricted Schedule III drug will happen on Dec. 2, after the …
Cannabis Stocks Slide After DEA Pushes Pot Reform to December
Cannabis stocks fell after federal regulators scheduled a December hearing on a proposal to reclassify marijuana as a less dangerous drug, pushing a final ruling on the measure past this fall’s …
Cannabis stocks on watch as DEA sets hearing on marijuana rescheduling
Cannabis-related stocks will come under investor scrutiny on Tuesday after the Drug Enforcement Administration (DEA) scheduled a public hearing to consider different views on the U.S. Justice …
Organigram Supports Cannabis In Germany With $15M Initial Investment In This Berlin Marijuana Co.
Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) announced on Tuesday a strategic investment aimed at expanding its presence within the burgeoning European cannabis market. What Happened The …
Cannabis Vs. Coca-Cola And Marlboro: Marijuana Market Growth Outpaces Alcohol, Tobacco And CPG Giants
Recent financial data from Beacon Securities compares key financial metrics across the alcohol, tobacco and cannabis industries, showing that cannabis is set to outpace major players like Coca-Cola …
Nine In 10 Americans Back Marijuana Legalization: What It Means For The Future Of Cannabis
Public support for marijuana legalization is on the rise in the US … This event, known for its focus on cannabis investment and branding, follows a successful Spring edition in Hollywood, Florida, …
3 Cannabis Stocks to Buy on the Dip: June 2024
Senate Majority Leader Chuck Schumer and Senate Finance Chairman Ron Wyden — last month reintroduced legislation that would take cannabis off the list of federal controlled substances. In my view, the …
DEA’s Proposed Rule to Reschedule Marijuana Could Reduce Obstacles to Medical Research but Public Input Is Needed to Fill in Knowledge Gaps
In sum, rescheduling marijuana will ease research barriers, which could invite investment by pharmaceutical companies with robust research and development capabilities to discover new FDA-approved …
Recent Comments